Robinswood Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1K Hold
83
0.01% 232
2026
Q1
$18.1K Buy
83
+47
+131% +$10.4K 0.01% 234
2025
Q4
$8.22K Hold
36
﹤0.01% 279
2025
Q3
$8.34K Hold
36
﹤0.01% 270
2025
Q2
$6.68K Hold
36
﹤0.01% 282
2025
Q1
$7.54K Hold
36
﹤0.01% 264
2024
Q4
$6.4K Hold
36
﹤0.01% 231
2024
Q3
$7.11K Hold
36
﹤0.01% 233
2024
Q2
$6.17K Hold
36
﹤0.01% 249
2024
Q1
$6.51K Hold
36
﹤0.01% 173
2023
Q4
$5.58K Hold
36
﹤0.01% 175
2023
Q3
$5.37K Hold
36
﹤0.01% 178
2023
Q2
$4.85K Buy
+36
New +$5.28K ﹤0.01% 170

Other funds holding ABBV

Robinswood Financial's ABBV Position: Q2 2026 in Review

Robinswood Financial held its AbbVie (ABBV) position steady in Q2 2026 at 83 shares worth $21.1K. The position accounts for 0.01% of the portfolio, ranked #232.

Robinswood Financial first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Robinswood Financial held 83 shares of AbbVie worth $21.1K as of Q2 2026.
  • Robinswood Financial left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.01% of Robinswood Financial's portfolio in Q2 2026, its #232 holding.
  • Robinswood Financial first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.